National Breast and Ovarian Cancer Centre (NBOCC)

This clinical practice guideline, based on high-level evidence, provides clinicians with guidance about the use of chemotherapy in the management of women with advanced breast cancer. The guideline, funded by the National Breast Cancer Foundation, has been endorsed by the Medical Oncology Group of Australia, the Faculty of Radiation Oncology at the Royal Australian and New Zealand College of Radiologists and the Royal Australasian College of Surgeons.

A clinical practice guideline developed by NBOCC. This document supplements guideline recommendation 25 about follow-up care contained in the Clinical Practice Guideline for the Management of Early Breast Cancer, 2nd edition 2001

This summary is designed to assist general pracitioners (GPs) in managing aspects of follow-up care and support for women following completion of active treatment for early breast cancer. It is based on clinical practice guideline Recommendations for follow-up of women with early breast cancer.

Synoptic breast imaging report including imaging clasification (1-5) desktop card.

A resource for clinicians to support discussions with women diagnosed with DCIS to improve their understanding about their diagnosis, prognosis, treatment and support.

This information has been developed to support a discussion with a woman concerned about her family history and covers surveillance for ovarian cancer for women at high or potentially high risk.

A total of 2,474 Australian women with early invasive breast cancer which were treated by breast surgeons participating in the National Breast Cancer Audit (NBCA) in 2006 were analysed for this report. The majority of participating surgeons were full members of the Breast Section of the Royal Australasian College of Surgeons (RACS). These cases represented invasive breast cancers entered in the RACS NBCA database to August 2007. Details of these cancers and of their management are described in this report by age at diagnosis, treatment centre location, and referral source. Invasive breast cancers recorded by the NBCA among New Zealand women are not addressed.

This information covers screening for ovarian cancer i.e. the testing of women at population risk who have no symptoms that might be ovarian cancer. It has been developed to support discussion with a woman about screening for ovarian cancer.

A tool for managing distress.

The distress thermometer is on page 10 of this document made available by the National Comprehensive Cancer Network (www.nccn.org). Registration is required to access their document.

Other documents in this resource:

• Psychosocial care referral explanatory notes (PCRG)
• Psychosocial care referral checklist (PCRG-2)

This document is the appendix to Psychosocial factors and the risk of developing breast cancer.

A full report on the National Multidisciplinary Care (MDC) Demonstration Project, National Profile Study of Multidisciplinary Care and Observational Study of Multidisciplinary Care. (368 pages)

A 61 page summary (MDS) of the full report is also available.

National Breast and Ovarian Cancer Centre has announced the release of its report Breast cancer risk factors: a review of the evidence, an up-to-date review of epidemiological studies about risk factors for breast cancer, including gender, age, family history, place of residence, hormone levels, lifestyle factors, medical history and environmental factors.

National Breast and Ovarian Cancer Centre (NBOCC) has developed breast cancer specific data items for clinical cancer registration and data dictionary definitions to facilitate comparative analysis and, where appropriate, data pooling. The data dictionary definitions were developed through an NBOCC multidisciplinary working group, in consultation with key stakeholders, and are drawn from data dictionary definitions in key datasets already in use across Australia. (54 page document)

A total of 4,979 Australian women with early invasive breast cancer were treated by breast surgeons participating in the National Breast Cancer Audit (NBCA) in 2007, the majority of whom were full members of the Breast Section of the Royal Australasian College of Surgeons. Details of these cancers and of their management are described in this report by age at diagnosis, treatment centre location, and referral source. In situ lesions, and invasive cancers recorded by the NBCA among New Zealand women, are not addressed.

This new resource, including the Risk of Malignancy Index, provides information to assist clinicians identify those women who should be referred to a gynaecological oncologist

This summary is designed to help general practitioners (GPs) answer patients’ questions about sentinel node biopsy and manage follow-up care for women who have had the procedure.

This guide for pathologists, surgeons, radiologists and oncologists has been updated to reflect the latest evidence and consensus opinion in relation to the handling, examination and reporting of invasive carcinoma and ductal carcinoma in situ (DCIS). Includes updated versions of synoptic reports for invasive carcinoma and DCIS.

Included with this resource

PAT-2

PAT-3

PAT-4

Synoptic report card as part of  PAT-1 The pathology reporting of breast cancer: a guide (3rd edition) (952.96 kB)

Synoptic report card.

Synoptic reporting of ductal carcinoma insitu form, as part of  PAT-1 The pathology reporting of breast cancer: a guide (3rd edition) (952.96 kB)

Synoptic reporting of invasive carcinoma form, as part of  PAT-1 The pathology reporting of breast cancer: a guide (3rd edition) (952.96 kB)

4 page summary brochure supplement

A clinical practice guideline developed by NBOCC. This document supplements guideline recommendations 22, 24a and 24b about the use of endocrine therapy in National Breast Cancer Centre (NBCC) Clinical Practice Guidelines for the Management of Advanced Breast Cancer, 2nd edition, 2001 (page 9). 20 page document.

A guide for health professionals. Multi-Disciplinary Care principles for advanced disease are based on the Principles of Multidisciplinary Care developed by the NBCC and adapted to reflect the role of MDC teams in the advanced disease setting.

A clinical practice guideline developed by NBOCC. This document supplements guideline recommendation 9 about axillary node dissection (page 8) and information about sentinel node biopsy (page 57) contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.

A clinical practice guideline developed by NBOCC. This document supplements systemic adjuvant therapy guideline recommendations 12-22 (pp 8-10), specially those about chemotherapy regimens contained in the Clinical practice guidelines for the management of early breast cancer, 2nd edition 2001.

The guide has been developed to support Health professionals in the care of men and women who develop lymphoedema after treatment for cancer.

A systematic review has been undertaken to identify evidence for the administration of neoadjuvant chemotherapy before cytoreductive surgery is performed. Twenty-eight articles were eligible for inclusion in the review (two systematic reviews and 24 comparative trials). 34 page document.

Review of research evidence on secondary lymphoedema: Incidence, prevention, risk factors and treatment

Notes to assist health professionals in completing the Psychosocial care referral checklist.

Other documents in this resource:

• Psychosocial care referral checklist (PCRG-2)
• Distress thermometer (PCRG-3)

Other documents in this resource:

• Psychosocial care referral explanatory notes (PCRG)
• Distress thermometer (PCRG-3)

A National Data Strategy to improve access to information about breast and ovarian cancer. 18 page document.

Report from a plenary symposium held at the 34th Annual Scientific Meeting of the Clinical Oncological Society of Australia. 17 page document.

The aim of this review was to compare third generation aromatase inhibitors (AIs) to antioestrogens and progestins in the treatment of post-menopausal women with hormone receptor-positive metastatic breast cancer.

This review was designed to update the report A Systematic Review of Intraoperative Radiotherapy in Early Stage Breast Cancer published in 20021 by ASERNIP-S (Australian Safety and Efficacy Register of New Interventional Procedures - Surgical). 3 page document.

This is a summary that may be helpful for general practitioners in answering patient’s questions about trastuzumab. It is based on clinical practice guideline  HERG - Recommendations for Trastuzumab (Herceptin®) for treatment of HER2-positive breast cancer (291.85 kB).

A systematic review of the best available evidence on the use of trastuzumab (Herceptin®) in breast cancer.

The workshop recommendations provide guidance to multidisciplinary teams and health services about medicolegal implications of a multidisciplinary approach to cancer care. 19 page document.

The primary research questions of this systematic review assessed the benefits and harms of using sentinel node biopsy compared to axillary lymph node dissection to detect cancer spread in early (operable) breast cancer and cancer recurrence and survival outcomes for patients receiving sentinel node biopsy. 49 page document.

The aim of this systematic review was to determine the effectiveness of taxane-containing chemotherapy regimens, compared to non-taxane-containing chemotherapy regimens. 35 page document.

The National Breast Cancer Centre’s guidelines provide guidance for clinicians about the use of Herceptin® in the treatment of both early and advanced disease.

This document is an update of Chapter 6 and Appendix G contained in the NBCC
Breast imaging: a guide for practice, 2002 (resource code BIG).

2 page document.

The research question addressed by the systematic review was: Does the use of magnetic resonance imaging (MRI) instead of, or in addition to, other modalities improve the diagnosis of breast cancer during screening of asymptomatic women at high risk of breast cancer? Where possible, the review also investigated the impact of age and risk factor subgroup upon the relative diagnostic performance of MRI. 79 page document.

Training workshop for Aboriginal and Torres Strait Islander health workers. 20 page document.

Ovarian cancer in Australia: an overview, 2006 brings together under one cover the most recent information available on the epidemiology, public health and health services impact of ovarian cancer on Australia women. 47 page document.

Breast cancer in Australia: an overview, 2006 brings together under one cover the most recent information available on the epidemiology, public health and health services impact of breast cancer in Australia. 96 page document.

Recommendations for aromatase inhibitors as adjuvant endocrine therapy for post-menopausal women with hormone receptor-positive early breast cancer.

This document supplements guideline recommendation 19 about the use of tamoxifen for the management of post-menopausal women with hormone receptor-positive early breast cancer contained in the NBCC Clinical Practice Guidelines for the Management of Early Breast Cancer, 2nd edition, 2001 (page 9).

Supporting evidence for the national breast cancer centre hormonal therapies guidelines working group. 45 page document.

A report and recommendations from a National Breast Cancer Forum series - July 2006